
Many bacteria steal cholesterol from the cells that they infect in order to grow and cause disease. Shown is Anaplasma phagocytophilum bacteria living in vacuoles (red circles) inside a tissue culture cell, the nucleus of which is blue. Cholesterol-carrying proteins (green) are accumulated inside the bacterial vacuoles. VCU researchers and collaborators discovered that an FDA-approved class of drugs called FIASMAs inhibit bacterial cholesterol acquisition to stop the growth of or kill A. phagocytophilum and other disease-causing intracellular bacteria. FIASMAs could potentially be repurposed to treat a number of infectious diseases. (Photo courtesy of Life Science Alliance).
Some antidepressants could potentially be used to treat a wide range of diseases caused by bacteria living within cells, according to work by researchers in the Virginia Commonwealth University School of Medicine and collaborators at other institutions.
Research published in the April print edition of the journal Life Science Alliance, shows that antidepressant drugs called FIASMAs, including desipramine, amitriptyline, and nortriptyline, halt the growth or kill four different intracellular bacterial pathogens in tissue cell culture and animal models.
“Antibiotic options for diseases caused by intracellular bacteria are limited because many of these drugs cannot penetrate our cell membranes. In essence, the bacteria are protected,” said Jason Carlyon, Ph.D., leader of the study and professor in the VCU Department of Microbiology and Immunology.
Tetracycline antibiotics are most commonly prescribed to treat intracellular bacterial infections because they can cross cell membranes to reach the microbes. However, tetracyclines can cause allergic reactions in some patients and physicians advise against their use by pregnant women and children due to undesirable side effects. Additionally, antibiotic resistance in some intracellular bacteria has been reported.
“It would be highly beneficial to have a class of drugs to treat such diseases in patients for whom tetracyclines are contraindicated,” Carlyon said. “These drugs could provide an alternative to antibiotics or even be used in conjunction with them as an augmentation approach to treat infections that typically require prolonged courses of antibiotic therapy, such as those caused by Chlamydia pneumoniae and Coxiella burnetti.”
The team of researchers from VCU, Indiana University Medical Center, University of Nebraska Medical Center, University of Arkansas for Medical Sciences, and the University of South Florida, including Carlyon and lead author Chelsea Cockburn, an M.D.-Ph.D. candidate, are the first to investigate the mechanisms by which FIASMAs target multiple intracellular bacteria in detail.
The scientists tested FIASMA susceptibility for four bacterial species that cause human granulocytic anaplasmosis, a tick-borne disease that attacks white blood cells called neutrophils and can be fatal to immune compromised individuals; Q fever, a debilitating pneumonic disease; and two chlamydia infections.
FIASMAs ultimately disrupt how cholesterol, a key nutrient utilized by many intracellular pathogens, traffics inside cells to alter bacterial access to the lipid. The researchers first proved FIASMA treatment efficacy by halting anaplasmosis in both tissue culture and mice. Next, they extended their observations to demonstrate that FIASMA treatment killed the Q fever agent,Coxiella burnetii, and partially inhibited chlamydial infections in cell culture.
“Since FIASMAs influence cholesterol trafficking in the cell and cholesterol plays a role in so many facets of our biology, they have been used to treat a wide variety of conditions and diseases,” Carlyon said.
He added that the effect of FIASMAs on intracellular cholesterol ultimately bypasses the need to directly target the bacteria.
“What is so exciting about this study is that the class of drugs we evaluated targets an enzyme in our cells regulating cholesterol, not the bacteria,” Carlyon said. “I do not envision the pathogens being able to develop resistance to this treatment because it is targeting a host pathway that they very much need to grow and survive inside of the body.”
Learn more: Certain antidepressants could provide a frontline treatment for multiple infectious diseases, testing shows
The Latest on: Alternative to antibiotics
[google_news title=”” keyword=”alternative to antibiotics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alternative to antibiotics
- US benchmarking data provide picture of pediatric outpatient antibiotic prescribingon June 2, 2023 at 1:29 pm
A team of US researchers reported benchmarking data for outpatient prescribing in pediatric settings yesterday in the Journal of the Pediatric Infectious Diseases Society. For the study, institutions ...
- European Parliament adopts resolution to address antimicrobial resistanceon June 2, 2023 at 11:11 am
The resolution calls on EU nations to regularly update National Action Plans against AMR and to improve data collection on drug-resistant pathogens and antibiotic use.
- Antibiotics most common documented medication allergens: Qatar studyon June 2, 2023 at 10:42 am
Antibiotics were the most common documented medication allergens among the patients in a tertiary hospital in Qatar , according to a study conducted on 2,431 patients ...
- Novel Antibiotics Offer an Alternative to Fighting Resistant Bacteriaon June 1, 2023 at 7:30 am
Researchers have now modified the chemical structure of naturally occurring peptides to develop antimicrobial molecules that bind to novel targets in the bacteria’s metabolism.
- The Healthiest Butter To Eat For Weight Loss, According To Nutritionistson May 26, 2023 at 3:31 pm
Butter plays a starring role in many of our favorite recipes. It enhances flavor, keeps your food tender, and locks in moisture. But, as you probably already know, too much of a good thing can cause ...
- PhageLab's AI-Powered Biotech Platform: Solving The Global Bacterial Threaton May 24, 2023 at 3:56 am
Today, an especially innovative developer of highly effective alternatives to antibiotics, a venture-capital-backed company called PhageLab, offers livestock producers a new way to defend against ...
- Drugs — from cancer meds to children's Tylenol — are in short supply in the U.S.on May 23, 2023 at 2:55 pm
Nationwide drug shortage is a "tragedy happening in slow motion," a cancer surgeon says. "Patients simply deserve better." ...
- Public acceptance of phage therapy is already moderately high, study showson May 22, 2023 at 11:26 pm
This has revitalized the development of antibiotic alternatives, such as phage therapy, which was first explored over a century ago but abandoned in many countries in favor of antibiotics.
- Public aware of and accepts use of bacteria-killing viruses as alternative to antibiotics, says studyon May 22, 2023 at 6:25 pm
The public is in favor of the development of bacteria-killing viruses as an alternative to antibiotics—and more efforts to educate will make them significantly more likely to use the treatment ...
- Public aware of and accept use of bacteria-killing viruses as alternative to antibiotics, study showson May 22, 2023 at 11:59 am
The public are in favour of the development of bacteria-killing viruses as an alternative to antibiotics – and more efforts to educate will make them significantly more likely to use the ...
via Bing News